http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2588191-B2

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D475-04
filingDate 1987-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1997-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1997-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2588191-B2
titleOfInvention Therapeutic agent for improving neurological symptoms associated with malignant tumors and severe viral infections
priorityDate 1987-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534828
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425591816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452389652
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60960
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66600568
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398654
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135409471
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398579
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419486566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12035
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135449517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492817
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453340847
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449630271

Total number of triples: 30.